Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

BACKGROUND: We have constructed and clinically evaluated a hypoallergenic vaccine for grass pollen allergy, BM32, which is based on fusion proteins consisting of peptides from the IgE binding sites of the major grass pollen allergens fused to preS (preS1 + preS2), a domain of the hepatitis B virus (...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelius, Carolin, Schöneweis, Katrin, Georgi, Fanny, Weber, Milena, Niederberger, Verena, Zieglmayer, Petra, Niespodziana, Katarzyna, Trauner, Michael, Hofer, Harald, Urban, Stephan, Valenta, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049759/
https://www.ncbi.nlm.nih.gov/pubmed/27568223
http://dx.doi.org/10.1016/j.ebiom.2016.07.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049759/
https://www.ncbi.nlm.nih.gov/pubmed/27568223
http://dx.doi.org/10.1016/j.ebiom.2016.07.023

Ejemplares similares